Colgate-Palmolive (CL) Insider Daniel B. Marsili Sells 19,500 Shares of Stock

Colgate-Palmolive (NYSE:CL) insider Daniel B. Marsili sold 19,500 shares of Colgate-Palmolive stock in a transaction on Monday, April 16th. The shares were sold at an average price of $71.85, for a total transaction of $1,401,075.00. Following the completion of the sale, the insider now directly owns 77,935 shares in the company, valued at approximately $5,599,629.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Shares of CL opened at $71.08 on Thursday. Colgate-Palmolive has a 52-week low of $67.86 and a 52-week high of $77.91. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. The firm has a market cap of $63,224.85, a price-to-earnings ratio of 25.11, a price-to-earnings-growth ratio of 2.72 and a beta of 0.74.

How to Become a New Pot Stock Millionaire

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter in the previous year, the company posted $0.75 EPS. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. analysts forecast that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th will be paid a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 2.36%. The ex-dividend date is Thursday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s payout ratio is 55.75%.

CL has been the topic of a number of research analyst reports. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday, January 15th. Jefferies Group reissued a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 26th. BNP Paribas cut shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Barclays set a $75.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a research note on Thursday, March 15th. Finally, Citigroup lifted their price target on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $77.91.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. boosted its stake in Colgate-Palmolive by 1.4% during the 4th quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock worth $3,950,614,000 after purchasing an additional 711,972 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Colgate-Palmolive by 2.1% during the 4th quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock valued at $675,751,000 after acquiring an additional 188,455 shares during the last quarter. First Eagle Investment Management LLC boosted its position in shares of Colgate-Palmolive by 35.8% during the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after acquiring an additional 1,750,417 shares during the last quarter. OppenheimerFunds Inc. boosted its position in shares of Colgate-Palmolive by 2.8% during the 4th quarter. OppenheimerFunds Inc. now owns 6,173,804 shares of the company’s stock valued at $465,813,000 after acquiring an additional 166,537 shares during the last quarter. Finally, APG Asset Management N.V. boosted its position in shares of Colgate-Palmolive by 33.2% during the 4th quarter. APG Asset Management N.V. now owns 5,421,184 shares of the company’s stock valued at $340,630,000 after acquiring an additional 1,350,400 shares during the last quarter. 73.64% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally posted by Week Herald and is the property of of Week Herald. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://weekherald.com/2018/04/19/colgate-palmolive-cl-insider-daniel-b-marsili-sells-19500-shares-of-stock.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply